ClinicalTrials.govpublic full text
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
giant cell arteritis, giant cell arteritis,, tocilizumab, aortitis, remission, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 858099
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.